Indications and uses
Acne treatment and helps prevent new acne blemishes.
Acne treatment and helps prevent new acne blemishes.
Clean the skin thoroughly before applying this product. Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day
Salicylic acid 2%
acne treatment
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Acne treatment and helps prevent new acne blemishes.
For external use only.
skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Avoid contact with eyes. If contact occurs, flush thoroughly with water.
Water, poloxamer 407, propylene glycol, PEG-400, laureth-4, menthol, bisabolol.
Tough on acne
Gentle on your skin
Anti-acne IntelliGel™
BRODA Acne Spot Treatment
Broda Acne Treatment Pen
IntelliGel™ Technology
Suitable for sensitive skin
Maximum strength with 2% beta hydrox acid
Forms TrueSkin invisible patch
No peeling or flaking
Won't dry your skin
Alcohol-free Hydrogel
NET WT. 0.071 oz. (2g) - 0.71 oz. (20 g)
Distributed by:
Broda International, LLC
10 Barley Court
Plainsboro, NJ 08536
Manufactured and packaged in the USA
www.broda.com
Patent pending
BRODA™
Anti-acne IntelliGel™
Developed with a proprietary break-through IntellGel™ technology that delivers maximum strength acne medication to effectively penetrate pores to clear most acne blemishes and help prevent new acne pimples.
res
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1543172 | Broda Acne Spa 2 % Topical Gel | PSN | 5 |
| 346298 | salicylic acid 2 % Topical Gel | PSN | 5 |
| 1543172 | salicylic acid 0.02 MG/MG Topical Gel [Broda Acne Spa] | SBD | 5 |
| 346298 | salicylic acid 0.02 MG/MG Topical Gel | SCD | 5 |
| 1543172 | Broda Acne Spa 0.02 MG/MG Topical Gel | SY | 5 |
| 1543172 | Broda Acne Spa 2 % Topical Gel | SY | 5 |
| 346298 | salicylic acid 2 % Topical Gel | SY | 5 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54111-112-50 | BRODA Acne | 20 g in 1 TUBE | GEL | 20 | 5 | |
| 54111-112-51 | BRODA Acne | 2 g in 1 TUBE | GEL | 2 | 5 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 1 | |
| LAURETH-4 | INACTIVE INGREDIENT | 6HQ855798J | 1 | |
| LEVOMENOL | INACTIVE INGREDIENT | 24WE03BX2T | 1 | |
| MENTHOL | INACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| POLOXAMER 407 | INACTIVE INGREDIENT | TUF2IVW3M2 | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54111-112 | 54111-112-50, 54111-112-51 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| WATER | 059QF0KO0R | IACT |
| POLOXAMER 407 | TUF2IVW3M2 | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| LAURETH-4 | 6HQ855798J | IACT |
| MENTHOL | L7T10EIP3A | IACT |
| LEVOMENOL | 24WE03BX2T | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MENTHOL | MENTHOL | L7T10EIP3A | GEL / TOPICAL | 0.1 %w/w | ||
| LAURETH-4 | LAURETH-4 | 6HQ855798J | GEL / TOPICAL | 60 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TOPICAL | 4522 mg | ||
| LAURETH-4 | LAURETH-4 | 6HQ855798J | GEL / TOPICAL | 60 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | GEL / TOPICAL | 6300 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | GEL / TOPICAL | 28 mg | ||
| LAURETH-4 | LAURETH-4 | 6HQ855798J | GEL / TOPICAL | 60 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | GEL / TOPICAL | 6300 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | GEL / TOPICAL | 0.1 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TOPICAL | 4522 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TOPICAL | 4522 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | GEL / TOPICAL | 28 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | GEL / TOPICAL | 6300 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | GEL / TOPICAL | 28 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | GEL / TOPICAL | 0.1 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BRODA Acne | SALICYLIC ACID | Bentley Laboratories, LLC | b7e1f105-8998-46a5-b1ae-85d21790b816 | 2024-12-27 | Warnings | 54111-112-50 54111-112-51 54111-112 54111011251 54111011250 d02e577d-3cb9-4906-ae3f-79f5ced8be19 b7e1f105-8998-46a5-b1ae-85d21790b816 |
Adverse event summaries are temporarily unavailable. Other product information remains available.